Clinical trial · Interventional
Intrathecal Dexmedetomidine vs Midazolame
Prospective Randomized Controlled Clinical Trial to Compare Intrathecal Dexmedetomidine Versus Midazolame in Orthopedic Cancer Surgeries
NCT06315634CI-TRIAL-00075138completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective Randomized Controlled Clinical Trial to Compare Intrathecal Dexmedetomidine Versus Midazolame in Orthopedic Cancer Surgeries
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Postoperative Pain | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bupivacain | Drug | — | UNRESOLVED |
| Dexmedetomidine | Drug | — | UNRESOLVED |
| Midazolam | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- Heavy Bupivacaine plus normal saline
- description
- 2.5 ml of 0.5% hyperbaric Bupivacaine plus 0.5 ml 0.9 % saline
- interventionNames
- Drug: Bupivacain
- type
- EXPERIMENTAL
- label
- Heavy Bupivacaine plus dexmedetomidine
- description
- 2.5 ml of 0.5% hyperbaric Bupivacaine plus 5 micrograms dexmedetomidine in 0.5 ml 0.9 % saline
- interventionNames
- Drug: Dexmedetomidine
- Drug: Bupivacain
- type
- EXPERIMENTAL
- label
- Heavy Bupivacaine plus midazolam
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Patients undergoing lower limb orthopedic cancer surgery. * ASA I, II, III. * Age 20 to 70 year * Healthy volunteers Exclusion Criteria: * Age less than 20 and older than 70. * ASA IV, V. * patients' refusal. * patients with coagulopathy. * patients with severe valvular stenosis * patients with infection at site of injection
References
Publications (0)
Data not yet available
No reference posted for this study.